Overview

Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process

Status:
NOT_YET_RECRUITING

Trial end date:
2026-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to estimate efficiency, tolerance, safety of "Foscelantan, medicinal plate 4.0x5.0 cm in package No. 1" among adult patients who have purulent-inflammatory processes of the skin and soft tissues due to the neuropathic form of diabetic foot syndrome or chronic venous insufficiency, phase I-II of the wound process.

Phase:

PHASE2

Details

Lead Sponsor:

Research Institute for Physical Chemical Problems of the Belarusian State University

Collaborators:

The 10th Minsk City Clinical Hospital
Unitary Enterprise UNITEHPROM BSU
Vitebsk Regional Clinical Hospital